UPL obtains regulatory approval for Arysta LifeScience acquisition

The company is expected to complete the transaction with regards to acquisition by Jan 31, 2019.

Jan 25, 2019 03:01 IST India Infoline News Service

Acquisition Concept
UPL, in a press note to the exchanges, informed that the company has obtained all regulatory approvals for the acquisition of 100% stake of Arysta LifeScience.

Accordingly, the company is expected to complete the transaction with regards to acquisition by January 31, 2019, said UPL in a press release after market hours to the exchanges on Thursday.

UPL Ltd's share price ended at Rs747.50, down by Rs15.6 or 2.04%, from its previous closing of Rs763.10 on the BSE.
The scrip opened at Rs765 and touched a high and low of Rs765 and Rs743.65, respectively. A total of, 21,85,939 (NSE+BSE) shares have traded on the counter. The current market cap of the company is Rs38,065.72cr.

Related Story